Delivery Order SPE2DB25D3012-SPE2DB25FWWVE

Award Date 4/14/25
Potential Completion Date 5/5/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,187.06 firm fixed-price delivery order is for the supply of Venclexta 100 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 contract is for the supply of 4,567,998,903 units of the prescription medication Venclexta 100 mg tablets. The award has an ultimate completion date of May 13, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 firm fixed-price contract is for the delivery of 4,567,503,935 units of the drug Venclexta 100 mg tablets. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $8,162.89 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of 4,558,791,053 units of the pharmaceutical product Venclexta 100 mg tablets. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.15 firm fixed-price delivery order is for the supply of Venclexta 100 mg tablets. The contract has an ultimate completion date of April 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug Venclexta 100 mg tablets. The contract is a delivery order with a firm fixed price of $8,880.15 and a completion date of May 16, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 Firm Fixed Price Delivery Order contract is for VENCLEXTA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract, valued at $8,880.15, is for the delivery of Venclexta 100 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide a comprehensive range of...
This is a $8,880.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 4,565,266,344 units of the prescription drug VENCLEXTA 100 mg tablets. The contract has an ultimate completion date of August 16, 2024 and was awarded on July 26, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense (Defense agency) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,144.15 firm-fixed-price delivery order is for the supply of Venclexta 100 mg tablets. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for the...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWWVE
    Delivery Order

This is a $9,728.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The award is not associated with a set-aside program. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, AmerisourceBergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 7/14/25, 10:53 AM